An Open-Label, Multicentre, Dose-Escalation, First-In-Human Phase I Study To Evaluate Safety, Tolerability And Antineoplastic Activity Of Oatd-02 (Dual Arginase 1 And Arginase 2 Inhibitor) In Patients With Selected Advanced And/Or Metastatic Solid Tumors.
OATD-02
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: An Open-Label, Multicentre, Dose-Escalation, First-In-Human Phase I Study To Evaluate Safety, Tolerability And Antineoplastic Activity Of Oatd-02 (Dual Arginase 1 And Arginase 2 Inhibitor) In Patients With Selected Advanced And/Or Metastatic Solid Tumors. ### Output: OATD-02